Home » Newsletters » BioWorld

BioWorld

Aug. 21, 1991

View Archived Issues

BIOTECHNICA LICENSES MGI's CORN GENE

APPLIED IMAGING BUYS DIVISION OF BRITISH FIRM

VIMRX SHIPS AIDS TREATMENT TO NIH

COLUMBIA RAISES $15 MILLION

PERSEPTIVE RAISES $6.75M IN FUNDING

FIVE MORE SUITS FILED AGAINST XOMA

COLLAGEN COMPLIES WITH LABELING CHANGES

TWO COMPANIES TEST IPO MARKET

AMGEN SELLS REAGENT, DIAGNOSTIC BUSINESSES

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...